Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
semaglutide oral dose US regulators approve Wegovy pill, first medication to treat obesity | US healthcare Product Type_Capsules Flavor:Strawberry GLP-3 RT (RETA)
GLP-3 RT (RETA)
The particles themselves are inert, but their presence confirms the remaining solution is significantly degraded
Product Type_Capsules
Flavor:Strawberry
In the STEP 1 trial, adults with obesity or overweight (without diabetes) who took weekly semaglutide lost about 15% of their body weight on average over 68 weeks, alongside lifestyle support, compared with about 2.4% in the placebo group
US$ 27.96
US$ 26.94
US$ 24.22
US$ 24.77
US$ 27.64
US$ 21.97
US$ 25.87
US$ 29.84
US$ 28.24
